Prolactinoma Screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m Bot: Removing from Primary care |
||
(4 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{CMG}}{{AE}}{{Anmol}} | {{Prolactinoma}} | ||
{{CMG}};{{AE}} {{Anmol}} | |||
==Overview== | ==Overview== | ||
Line 11: | Line 12: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
| |||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Neuroendocrinology]] | [[Category:Neuroendocrinology]] | ||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Endocrinology]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Neurology]] | |||
[[Category:Neurosurgery]] |
Latest revision as of 23:50, 29 July 2020
Prolactinoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Prolactinoma Screening On the Web |
American Roentgen Ray Society Images of Prolactinoma Screening |
Risk calculators and risk factors for Prolactinoma Screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]
Overview
There is insufficient evidence to recommend routine screening for prolactinoma.
Screening
There is insufficient evidence to recommend routine screening for prolactinoma.
References